Mr Michael L Hopen, MD | |
11455 N Meridian St Ste 100, Carmel, IN 46032-1679 | |
(317) 846-4223 | |
(317) 846-6063 |
Full Name | Mr Michael L Hopen |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 14 Years |
Location | 11455 N Meridian St Ste 100, Carmel, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689993347 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 01074351A (Indiana) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Indianapolis Ophthalmology Pc | 9335190354 | 6 |
News Archive
BioMimetic Therapeutics, Inc. today announced it will introduce Augmatrix Biocomposite Bone Graft, a new bone graft substitute product line, to surgeons and distributors at its exhibit booth during the American Academy of Orthopedic Surgeons (AAOS) meeting this week in San Francisco, CA.
Quanterix Corporation, the single molecule diagnostics company focused on developing and commercializing high sensitivity tests, announced the publication of a breakthrough study of the company's proprietary technology that demonstrates an unprecedented sensitivity for measuring a biomarker for prostate cancer recurrence.
Achalasia is a rare disease - it affects 1 in 100,000 people - characterized by a loss of nerve cells in the esophageal wall.
Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have found that a blood vessel-building gene boosts the ability of human bone marrow stem cells to sustain pancreatic recovery in a laboratory mouse model of insulin-dependent diabetes.
› Verified 6 days ago
Entity Name | Indianapolis Ophthalmology Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902910359 PECOS PAC ID: 9335190354 Enrollment ID: O20050208000292 |
News Archive
BioMimetic Therapeutics, Inc. today announced it will introduce Augmatrix Biocomposite Bone Graft, a new bone graft substitute product line, to surgeons and distributors at its exhibit booth during the American Academy of Orthopedic Surgeons (AAOS) meeting this week in San Francisco, CA.
Quanterix Corporation, the single molecule diagnostics company focused on developing and commercializing high sensitivity tests, announced the publication of a breakthrough study of the company's proprietary technology that demonstrates an unprecedented sensitivity for measuring a biomarker for prostate cancer recurrence.
Achalasia is a rare disease - it affects 1 in 100,000 people - characterized by a loss of nerve cells in the esophageal wall.
Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have found that a blood vessel-building gene boosts the ability of human bone marrow stem cells to sustain pancreatic recovery in a laboratory mouse model of insulin-dependent diabetes.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Michael L Hopen, MD 11455 N Meridian St Ste 100, Carmel, IN 46032-1679 Ph: (317) 846-4223 | Mr Michael L Hopen, MD 11455 N Meridian St Ste 100, Carmel, IN 46032-1679 Ph: (317) 846-4223 |
News Archive
BioMimetic Therapeutics, Inc. today announced it will introduce Augmatrix Biocomposite Bone Graft, a new bone graft substitute product line, to surgeons and distributors at its exhibit booth during the American Academy of Orthopedic Surgeons (AAOS) meeting this week in San Francisco, CA.
Quanterix Corporation, the single molecule diagnostics company focused on developing and commercializing high sensitivity tests, announced the publication of a breakthrough study of the company's proprietary technology that demonstrates an unprecedented sensitivity for measuring a biomarker for prostate cancer recurrence.
Achalasia is a rare disease - it affects 1 in 100,000 people - characterized by a loss of nerve cells in the esophageal wall.
Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have found that a blood vessel-building gene boosts the ability of human bone marrow stem cells to sustain pancreatic recovery in a laboratory mouse model of insulin-dependent diabetes.
› Verified 6 days ago
Dr. Kevin Enpei Lai, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10300 N Illinois St Ste 1000, Carmel, IN 46290 Phone: 317-805-2240 | |
John H Abrams, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 11455 N Meridian St, Suite 100, Carmel, IN 46032 Phone: 317-846-4223 Fax: 317-846-6063 | |
Derek T Sprunger, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 201 Pennsylvania Pkwy Ste 100, Carmel, IN 46280 Phone: 317-817-1333 | |
Stephen Roth Klapper, MD FACS Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 11900 N Pennsylvania St, Suite 104, Carmel, IN 46032 Phone: 317-818-1000 Fax: 317-818-1001 | |
Dr. Jerry Richard Myers, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 13405 Cherry Tree Rd, Carmel, IN 46033 Phone: 317-844-1436 | |
Dr. Mark Matson Kaehr, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10585 N Meridian St Ste 100, Carmel, IN 46290 Phone: 317-571-1501 Fax: 317-571-4806 | |
Dr. Jennifer Marie Nottage, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10300 N Illinois St, Carmel, IN 46290 Phone: 317-817-1765 |